Don't miss out on Monday 4th November 2024, when Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) will disclose its third quarter financial results after market close. Investors will have the chance to learn more about the company's performance during the quarter.
According to predictions from financial analysts on Wall Street, the company is expected to report an estimated per share $4.14 profit for the quarter. Furthermore, the company is anticipated to unveil a total revenue of $2.72 billion during this period.
The company's earnings report from the corresponding quarter of the previous year demonstrated a per-share income of $4.08. Additionally, the company achieved a total revenue of $2.48 billion during that specific period.
Projections for the company's annual performance have been shared by Wall Street analysts, with an estimated total revenue of $10.75 billion. Furthermore, they are predicting profit of $0.16 per share for the full year.
In addition, The firm will review the third quarter financial results on 4th November 2024 at 04:30 PM eastern time, in a conference call with public.
Vertex Pharmaceuticals Incorporated (VRTX) shares experienced a range of $463.15 to $475.49 on a day volume of 1.23 million shares. The stock closed Friday's regular trading session at $471.12, marking a 1.02 percent drop.
